Cyclo(Phe-Cys)

General Information


DRACP ID  DRACP04326

Peptide Name   Cyclo(Phe-Cys)

Sequence  FC

Sequence Length  2

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C12H16N2O3S

Absent amino acids  ADEGHIKLMNPQRSTVWY

Common amino acids  CF

Mass  28635

Pl  5.92

Basic residues  0

Acidic residues  0

Hydrophobic residues  1

Net charge  0

Boman Index  426

Hydrophobicity  265

Aliphatic Index  0

Half Life 
  Mammalian: 100 hour
  Yeast: >20 hour
  E.coli: >10 hour

Extinction Coefficient cystines  0

Absorbance 280nm  0

Polar residues  1

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 18436344

Title  The synthesis and anticancer activity of selected diketopiperazines

Doi Not available

Year  2008

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  18931

DRACP is developed by Dr.Zheng's team.